Focus Diagnostics – Part of DiaSorin Group
Focus Diagnostics’ product lines include the HerpeSelect® HSV serology, and a line DxSelect™ IFA and ELISA assays. Please read more about Serology diagnostics products here
The INNOTEST® assays from Fujirebio are solid-phase enzyme immunoassays for the quantitative determination of β-amyloid(1-42), β-amyloid(1-40), total tau, and phospho-tau(181P) in human cerebrospinal fluid. The combined use of these markers allows identification of AD pathology ante-mortem. Read more about B-Amyloid and TAU biomarkers here
Fujirebio Europe launched 2017 Lumipulse® G β-Amyloid 1-42, a fully automated assay aiding in the early diagnosis of neurodegeneration.
Vidia offers ELISAs and antibodies for infectious serology e.g. HHV-6, HSV, VZV. Read more on Vidia website.
Labsystems Diagnostics Oy
Labsystems Diagnostics Oy, a Finnish establishment develops and manufactures high-quality diagnostic tests globally for clinical laboratory and home use.
Biocard™ Celiac Test is a rapid immune chromatographic lateral flow test for the qualitative detection of anti-tissue transglutaminase IgA antibodies from a fingertip blood sample.
The professional test version also contains total IgA measuring system showing the presence of IgA antibodies in the sample which reduces the risk of false negatives due to rare IgA deficiency. (CE marked)
Easy to use C.pneumoniae and Mycoplasma pneumoniae IgM EIA kits provide accurate results by using highly specific antigens. The kits come with ready-to-use, well sufficient reagents and breakable, coded strips. IgG Remover (RF absorbent) is included in the IgM kits.
Product range includes e.g.
6600140 Toxoplasma gondii EIA Avidity IgG, 96 tests
3-028-000 Biocard Celiac Disease, 10 tests
3-018-110 Biocard Helicobacter pylori, 10 tests
3-034-000 Biocard Chlamydia pneumoniae IgM, 10 tests
3-035-000 Biocard Mycoplasma pneumoniae IgM, 20 tests
The OraQuick® HCV test is FDA approved for detecting HCV antibodies in fingerstick and venipuncture whole blood. Simple platform enables healthcare providers to deliver an accurate diagnosis in 20 minutes. Accuracy: Clinically proven performance, OraQuick® HCV is greater than 98% accurate.